InvestorsHub Logo
Followers 1880
Posts 137240
Boards Moderated 5
Alias Born 01/03/2007

Re: None

Tuesday, 01/12/2016 7:14:49 AM

Tuesday, January 12, 2016 7:14:49 AM

Post# of 344
Celgene weakness unjustified, says Wells Fargo
After Celgene preannounced lower than expected Q4 EPS and in-line revenue and the stock fell 5%, Wells Fargo says it was encouraged by the company's Q4 revenue and in-line REVLIMID sales. The firm thinks the company's guidance for 2016 and beyond was strong, and it believes the stock is "significantly undervalued